VF
CRBU icon

Virtu Financial’s Caribou Biosciences CRBU Stock Holding History

Virtu Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70K Buy
+36,609
New +$62.8K ﹤0.01% 1235
2024
Q2 		– Sell
-82,100
Closed -$422K – 1397
2024
Q1 		$422K Buy
82,100
+65,542
+396% +$404K 0.03% 475
2023
Q4 		$95K Sell
16,558
-16,491
-50% -$81.5K 0.01% 1038
2023
Q3 		$158K Buy
+33,049
New +$205K 0.02% 722
2022
Q4 		– Sell
-20,067
Closed -$212K – 1701
2022
Q3 		$212K Buy
20,067
+1,372
+7% +$12.8K 0.02% 833
2022
Q2 		$102K Buy
+18,695
New +$143K 0.01% 947
2021
Q4 		– Sell
-13,020
Closed -$311K – 1784
2021
Q3 		$311K Buy
+13,020
New +$318K 0.03% 698

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return